Cargando…

Safety of lotilaner flavoured chewable tablets (Credelio(TM)) after oral administration in cats

BACKGROUND: Lotilaner is a new member of the isoxazoline class for treatment of flea and tick infestations in cats. This laboratory study with lotilaner vanilla-yeast flavoured chewable tablets (Credelio(TM), Elanco) investigated the safety in healthy kittens starting at 8 weeks of age in a randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuntz, Emmanuelle A., Kammanadiminti, Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044082/ https://www.ncbi.nlm.nih.gov/pubmed/30001745 http://dx.doi.org/10.1186/s13071-018-2969-3

Ejemplares similares

Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)
por: Kuntz, Emmanuelle A., et al.
Publicado: (2017)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA
por: Chappell, Kimberly, et al.
Publicado: (2021)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
por: Karadzovska, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio(TM)) against Ixodes ricinus ticks on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs
por: Young, Lisa, et al.
Publicado: (2020)

Effectiveness of Credelio(®) Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs
por: Young, Lisa M., et al.
Publicado: (2021)

Efficacy of lotilaner (Credelio™) against experimentally induced infestations of the adult cat flea, Ctenocephalides felis, and flea eggs following oral administration to cats
por: Paarlberg, Tandy, et al.
Publicado: (2021)

Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio™) against Ctenocephalides felis on cats
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned cats in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2018)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs
por: Otaki, Hiroshi, et al.
Publicado: (2018)

A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluation of the speed of kill of lotilaner (Credelio™) against Ixodes ricinus ticks on dogs
por: Murphy, Martin, et al.
Publicado: (2017)

Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
por: Toutain, Céline E., et al.
Publicado: (2018)

Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Amblyomma cajennense (sensu lato) infestations of dogs
por: Lasmar, Pedro Veloso Facury, et al.
Publicado: (2018)

A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Early onset of pre-lethal effects of lotilaner (Credelio(®)) on Amblyomma americanum ticks on experimentally infested dogs
por: Wenger, Martha J., et al.
Publicado: (2021)

Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio™) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus
por: Baker, Kim, et al.
Publicado: (2018)

Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.
por: Snyder, Daniel E., et al.
Publicado: (2017)

Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) in juvenile and adult dogs
por: Riggs, Kari L., et al.
Publicado: (2021)

Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio™) against three common species of ticks affecting dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

In-home assessment of flea control and dermatologic lesions in dogs provided by lotilaner (Credelio(®)) and spinosad (Comfortis(®)) in west central Florida
por: Dryden, Michael W., et al.
Publicado: (2019)

Laboratory evaluations of the immediate and sustained efficacy of lotilaner (Credelio™) against four common species of ticks affecting dogs in North America
por: Murphy, Martin, et al.
Publicado: (2017)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

The novel isoxazoline ectoparasiticide lotilaner (Credelio™): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls)
por: Rufener, Lucien, et al.
Publicado: (2017)

Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method
por: Zaid, Abdel Naser, et al.
Publicado: (2015)

The intravenous and oral pharmacokinetics of lotilaner in dogs
por: Toutain, Céline E., et al.
Publicado: (2017)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA
por: Young, Lisa M., et al.
Publicado: (2021)

Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs
por: Snyder, Daniel E., et al.
Publicado: (2021)

Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) against natural intestinal nematode infections in dogs presented as veterinary patients in Europe
por: Hayes, Brad, et al.
Publicado: (2021)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio(®) Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe
por: Forster, Sophie, et al.
Publicado: (2021)

Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs
por: Lebon, Wilfried, et al.
Publicado: (2016)

Credelio® Plus: a novel oral endectocide for dogs
por: Traversa, Donato
Publicado: (2021)

Development of a chewable tablet from Dugdhāmalakyādi Yoga: An Ayurvedic preparation
por: Santhosh, S. B., et al.
Publicado: (2012)

Soft-Chewable Paracetamol Tablets by Melt Granulation Method: Formulation and Characterization
por: Sabere, Awis Sukarni Mohmad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1mhtq5olsfed185eo2mu9csu0